Literature DB >> 8227429

Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors.

C Limas1, R Bair, P Bernhart, P Reddy.   

Abstract

AIMS: To investigate the proliferative activity (given by the Ki67 index) of the normal, atypical, and neoplastic urothelium and its relation to the cellular reactivity for the epidermal growth factor (EGFr) and transferrin (Tfr) receptors.
METHODS: The Ki67 index and the level of EGFr and Tfr reactivity were determined on frozen sections from 82 patients with urothelial cancer. Relevant clinical material was reviewed to establish correlations with the degree of atypia and invasion.
RESULTS: Morphologically normal urothelium, whether derived from controls or patients with cancer, exhibited a low Ki67 index (less than 0.1%) and weak receptor reactivity. In transitional cell carcinomas (TCCs) the Ki67 index was increased: it ranged between 0.7% and 10% in non-invasive and exceeded 10% in 88% of the invasive TCCs. Strong positive reactions for EGFr were seen only in invasive TCCs, but in 47% of invasive TCCs the EGFr was not "overexpressed" and did not match the Ki67 index. A better correlation was found between the Ki67 index and the Tfr which was positive in 26% of the non-invasive and in 71% of the invasive tumours. All three variables were increased in severe atypia but varied considerably in lesser degrees of atypia.
CONCLUSIONS: Despite the absence of a close correlation, accelerated growth and enhanced receptor expression were characteristic of invasive cancers. These results suggest that the growth rate in TCCs is not causally related to overexpression of growth factor receptors but that the latter is an abnormality which may accompany the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227429      PMCID: PMC501514          DOI: 10.1136/jcp.46.9.810

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium.

Authors:  L Dubeau; P A Jones
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

2.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

3.  Proliferative activity of urothelium and tumors of renal pelvis, ureter, and urinary bladder evaluated by thymidine labeling.

Authors:  G Sufrin; J S Meyer; S A Martin; K Schechtman
Journal:  Urology       Date:  1984-03       Impact factor: 2.649

4.  Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies.

Authors:  E M Messing; P Hanson; P Ulrich; E Erturk
Journal:  J Urol       Date:  1987-11       Impact factor: 7.450

5.  A monoclonal antibody to the human epidermal growth factor receptor.

Authors:  M D Waterfield; E L Mayes; P Stroobant; P L Bennet; S Young; P N Goodfellow; G S Banting; B Ozanne
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

6.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

7.  Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

Authors:  R Sutherland; D Delia; C Schneider; R Newman; J Kemshead; M Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

8.  Transferrin receptors in human tissues: their distribution and possible clinical relevance.

Authors:  K C Gatter; G Brown; I S Trowbridge; R E Woolston; D Y Mason
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

9.  Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping.

Authors:  L G Koss; I Nakanishi; S Z Freed
Journal:  Urology       Date:  1977-04       Impact factor: 2.649

10.  Novel surface antigen expressed on dividing cells but absent from nondividing cells.

Authors:  W Judd; C A Poodry; J L Strominger
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Experimental animal model and RNA interference: a promising association for bladder cancer research.

Authors:  Leonardo Oliveira Reis; Tiago Campos Pereira; Wagner José Favaro; Valéria Helena Alves Cagnon; Iscia Lopes-Cendes; Ubirajara Ferreira
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

2.  Patterns of epidermal growth factor receptor amplification in malignant gliomas.

Authors:  G Sauter; T Maeda; F M Waldman; R L Davis; B G Feuerstein
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.